Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2026-01-02 @ 10:18 AM
Study NCT ID:
NCT01627561
Status:
COMPLETED
Last Update Posted:
2020-04-10
First Post:
2012-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2014-04-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-14
First Submit QC Date:
None
Study First Post Date:
2012-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-23
Results First Submit QC Date:
None
Results First Post Date:
2015-05-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-19
Last Update Post Date:
2020-04-10
Last Update Post Date Type:
ACTUAL